UPC (Universe Pharmaceuticals) Long-Term Debt: $0.00 Mil (As of Sep. 2025)


UPC Universe Pharmaceuticals Inc UPC
51 GF Score
Price $6.10
GF Value $5.21
Valuation Modestly Overvalued
! 10 Warning Signs
View Full Analysis

What is Universe Pharmaceuticals Long-Term Debt?

Universe Pharmaceuticals UPC -49.72% 51 Long-Term Debt is $0.00 Mil as of Sep. 2025. GuruFocus rates UPC with a GF Score™ of 51/100 and a GF Value™ of $5.21 (Modestly Overvalued). The stock has 10 warning signs investors should review.

Universe Pharmaceuticals's Long-Term Debt for the quarter that ended in Sep. 2025 was $0.00 Mil.

Universe Pharmaceuticals's quarterly Long-Term Debt declined from Sep. 2024 ($2.14 Mil) to Mar. 2025 ($2.07 Mil) and declined from Mar. 2025 ($2.07 Mil) to Sep. 2025 ($0.00 Mil).

Universe Pharmaceuticals's annual Long-Term Debt increased from Sep. 2023 ($0.00 Mil) to Sep. 2024 ($2.14 Mil) but then declined from Sep. 2024 ($2.14 Mil) to Sep. 2025 ($0.00 Mil).

Universe Pharmaceuticals  (NAS:UPC) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Universe Pharmaceuticals Long-Term Debt Related Terms

Universe Pharmaceuticals Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Universe Pharmaceuticals's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Universe Pharmaceuticals Long-Term Debt Chart

Universe Pharmaceuticals Annual Data
Trend Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 2.14 0.00

Universe Pharmaceuticals Semi-Annual Data
Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 2.08 2.14 2.07 0.00
UPC
51GF Score
Universe Pharmaceuticals Inc UPC
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $0.00 Mil mean?
Universe Pharmaceuticals (UPC) has a Long-Term Debt of $0.00 Mil as of Sep. 2025.
Is Universe Pharmaceuticals' Long-Term Debt too high?
Universe Pharmaceuticals' current Long-Term Debt is $0.00 Mil. Overall, Universe Pharmaceuticals has a GF Score™ of 51/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Universe Pharmaceuticals' Long-Term Debt compare to CPMD and SHPH?
Universe Pharmaceuticals' Long-Term Debt of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Universe Pharmaceuticals's current Long-Term Debt is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Universe Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Universe Pharmaceuticals (UPC) is currently considered Modestly Overvalued. The stock's GF Value™ is $5.21, compared to a current price of $6.10 — trading 17.1% above its estimated fair value. The current Long-Term Debt is $0.00 Mil. Universe Pharmaceuticals' overall GF Score™ is 51/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Universe Pharmaceuticals (UPC), the current Long-Term Debt is $0.00 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Universe Pharmaceuticals (UPC) Overvalued in 2026?

Based on GuruFocus' analysis, Universe Pharmaceuticals stock appears to be overvalued. The current stock price of $6.10 is trading 17.1% above its estimated GF Value™ of $5.21. GuruFocus considers Universe Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for UPC:

  • Long-Term Debt: $0.00 Mil
  • GF Value™: $5.21 vs. price of $6.10 (17.1% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the UPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Universe Pharmaceuticals Business Description

Address 265 Jingjiu Avenue, Jinggangshan Economic & Technological Development Zone, Jiangxi, Ji’an, CHN, 343100
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.
51GF Score

Get the complete analysis for UPC

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.10
Price
$5.21
GF Value